For generations, osteoporosis has quietly eroded the bones of aging populations, leaving millions vulnerable to fractures that can unravel independence and quality of life. Now, for the first time, researchers have turned stem cells loose on the disease in human patients, reporting a striking 94% reduction in fractures among a small trial group in September 2026. The result is preliminary — a first step, not a final answer — but it signals that medicine may be approaching a threshold where bone can be rebuilt rather than merely preserved.